Careful monitoring and personalised treatment can reduce the cost of treatment for those with rheumatoid arthritis.
Research conducted by the European League Against Rheumatism found that tailoring treatment to patients could see savings of around €2,595,557 per 272 patients over a three year period.
At the same time, this approach also increased effectiveness by an average of 3.67 quality-adjusted life years (QALYs), which is the measured by including pain levels, mobility and general mood.
Charlotte Krieckaert from the Jan van Breemen Research Institute in the Netherlands and lead author of the study said: "This study demonstrates that with careful monitoring and testing disease activity at six months, costs for RA treatment can be reduced and treatment effectiveness can actually increase."
The research found that personalised care reduced costs and improved QALY gained in 77.6 per cent of cases, and cut costs but was less effective on QALY in 22.4 per cent.
Find the nearest Barchester nursing home